259 related articles for article (PubMed ID: 30300395)
1. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
Juanbeltz R; Martínez-Baz I; San Miguel R; Goñi-Esarte S; Cabasés JM; Castilla J
PLoS One; 2018; 13(10):e0205277. PubMed ID: 30300395
[TBL] [Abstract][Full Text] [Related]
2. Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents.
Goñi Esarte S; Juanbeltz R; Martínez-Baz I; Castilla J; San Miguel R; Herrero JI; Zozaya JM
Rev Esp Enferm Dig; 2019 Jun; 111(6):445-452. PubMed ID: 31066286
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population.
Juanbeltz R; Castilla J; Martínez-Baz I; O'Leary A; Sarobe M; San Miguel R
Qual Life Res; 2019 Jun; 28(6):1477-1484. PubMed ID: 30666549
[TBL] [Abstract][Full Text] [Related]
4. Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C.
Gallach M; Vergara M; da Costa JP; Miquel M; Casas M; Sanchez-Delgado J; Dalmau B; Rudi N; Parra I; Monllor T; Sanchez-Lloansí M; Dosal A; Valero O; Calvet X
PLoS One; 2018; 13(12):e0208112. PubMed ID: 30566421
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study.
Vera-Llonch M; Martin M; Aggarwal J; Donepudi M; Bayliss M; Goss T; Younossi Z
Aliment Pharmacol Ther; 2013 Jul; 38(2):124-33. PubMed ID: 23725204
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.
Fagundes RN; Ferreira LEVVC; Pace FHL
PLoS One; 2020; 15(8):e0237005. PubMed ID: 32813740
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.
Huang R; Rao H; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun J; Jiang J; Wei L
Health Qual Life Outcomes; 2018 Jun; 16(1):124. PubMed ID: 29903024
[TBL] [Abstract][Full Text] [Related]
8. Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China.
Huang R; Shang J; Chen H; Li J; Xie Q; Feng J; Wei L; Rao H
BMC Infect Dis; 2024 Jan; 24(1):72. PubMed ID: 38200419
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D.
Jang ES; Kim YS; Kim KA; Lee YJ; Chung WJ; Kim IH; Lee BS; Jeong SH
Gut Liver; 2018 Jul; 12(4):440-448. PubMed ID: 29588435
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.
Youssef NF; El Kassas M; Farag A; Shepherd A
BMC Gastroenterol; 2017 Jan; 17(1):18. PubMed ID: 28109264
[TBL] [Abstract][Full Text] [Related]
11. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
12. Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.
Saeed S; Moodie EEM; Strumpf E; Gill J; Wong A; Cooper C; Walmsley S; Hull M; Martel-Laferriere V; Klein MB;
J Viral Hepat; 2018 Dec; 25(12):1507-1514. PubMed ID: 30141236
[TBL] [Abstract][Full Text] [Related]
13. Changes in Health-related Quality of Life for Hepatitis C Virus-Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response.
Gormley MA; Akiyama MJ; Rennert L; Howard KA; Norton BL; Pericot-Valverde I; Muench S; Heo M; Litwin AH
Clin Infect Dis; 2022 May; 74(9):1586-1593. PubMed ID: 34331539
[TBL] [Abstract][Full Text] [Related]
14. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H; Katano Y
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1066-1072. PubMed ID: 29727381
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.
Grotzinger KM; Younossi ZM; Giannini EG; Chen PJ; Rendas-Baum R; Theodore D
Health Qual Life Outcomes; 2016 Mar; 14():49. PubMed ID: 27004952
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.
Petta S; Adinolfi LE; Fracanzani AL; Rini F; Caldarella R; Calvaruso V; Cammà C; Ciaccio M; Di Marco V; Grimaudo S; Licata A; Marrone A; Nevola R; Pipitone RM; Pinto A; Rinaldi L; Torres D; Tuttolomondo A; Valenti L; Fargion S; Craxì A
J Hepatol; 2018 Jul; 69(1):18-24. PubMed ID: 29505844
[TBL] [Abstract][Full Text] [Related]
17. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
Ramsay J; Marsh J; Pedrana A; Andric N; Norman R; Cheng W; Webb S; Zeps N; Bellgard M; Graves T; Hellard M; Snelling T
BMC Infect Dis; 2020 Oct; 20(1):802. PubMed ID: 33121439
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life of patients with HIV/AIDS at a tertiary care teaching hospital in Ethiopia.
Belay YB; Ali EE; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2021 Jan; 19(1):24. PubMed ID: 33468153
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
[TBL] [Abstract][Full Text] [Related]
20. Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection.
Yi CH; Bair MJ; Wang JH; Wong MW; Liu TT; Lei WY; Liang SW; Lin L; Hung JS; Huang JF; Hsu YC; Chen CL
J Microbiol Immunol Infect; 2022 Aug; 55(4):643-650. PubMed ID: 35637143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
